Eric Lefebvre Net Worth & Insider Trades

Eric Lefebvre - Chief Medical Officer, Pliant Therapeutics, Inc

As of July 13, 2022

What is Eric Lefebvre's Net Worth?

The current estimated net worth of Pliant Therapeutics, Inc's Chief Medical Officer, Eric Lefebvre, is estimated to be about $2.32M . Eric Lefebvre owns about 138,436 units of Pliant Therapeutics, Inc common stock. In the last 2 years at Pliant Therapeutics, Inc, Eric Lefebvre has sold an estimated value of $1.25M worth.

What is Eric Lefebvre's Past Insider Trading?

Eric Lefebvre's largest sale order was 12,500 units , worth over $492.68K on March 19, 2021. In total, Eric Lefebvre has made about 6 transactions over 2 years of their time at Pliant Therapeutics, Inc. Eric Lefebvre usually trades in July, February, March, December, June and January, with the busiest year in 2021. The most recent transaction was a sale order of 3,000 units , worth over $60K on July 13, 2022.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What was Eric Lefebvre's Salary in 2020?

As Chief Medical Officer of Pliant Therapeutics, Inc, Eric Lefebvre has a total base salary of $425,462 . Eric Lefebvre received compensation valued at about $874,670 in 2020 after becoming Chief Medical Officer. The vast majority of their compensation came in the form of option awards of $288,633 , other earnings, plans or compensations of $209,176 , and other compensation of $11,400 .

What is Eric Lefebvre's' Mailing Address?

  • Mailing address is C/o Tobira Therapeutics, Inc. 701 Gateway Boulevard, #200 South San Francisco CA 94080 CA

Pliant Therapeutics, Inc Executive Compensation

Name
Year
Salary
Bonus
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Bernard J. Coulie 2020 $499,037 - $1,496,556 $351,000 $45,229 $2,391,822
Bernard J. Coulie 2019 $428,108 $2,000 $1,673,280 $219,193 $49,905 $2,372,486
Éric Lefebvre, M.D. 2020 $425,462 - $288,633 $209,176 $11,400 $874,670
Hans Hull, J.D. 2020 $372,491 - $279,025 $176,951 $11,400 $839,867
Hans Hull, J.D. 2019 $355,137 $75,000 $268,560 $136,369 $11,200 $846,266
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1746473/000114036121015256/nc10023533x1_def14a.htm

What are Pliant Therapeutics, Inc's Past Insider Trades?

Pliant Therapeutics, Inc's most recent insider trade came on September 14, 2022 by Bernard Coulie who sold 12,502 units worth $281.85K . In the last 2 years, insiders at Pliant Therapeutics, Inc have sold an estimated value of $3.48M and bought an estimated value of $417.69K worth of shares. Insider trading is most common in June, with the busiest year in 2021. The most active traders at the company are Bernard Coulie, President and CEO,  Lamont Keith Cummings, Chief Financial Officer,  and Eric Lefebvre, Chief Medical Officer .

PLIANT THERAPEUTICS, INC. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1